A PHASE 2 CLINICAL STUDY OF POMALIDOMIDE (CC-4047) MONOTHERAPY FOR CHILDREN AND YOUNG ADULTS WITH RECURRENT OR PROGRESSIVE PRIMARY BRAIN TUMORS
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Pomalidomide (Primary)
- Indications Brain cancer; Ependymoma; Glioma; Medulloblastoma
- Focus Therapeutic Use
- Sponsors Celgene Corporation
- 25 Sep 2017 Planned number of patients changed from 80 to 36.
- 30 Aug 2017 Status changed from not yet recruiting to recruiting.
- 02 Aug 2017 New trial record